This special series held annually at the AACR Annual Meeting and in collaboration with the AACR Chemistry in Cancer Research Working Group (CICR), comprises three sessions that consist of twelve 20-minute talks that must include a first disclosure of the chemistry and biology of small and large molecule agents that are actively being investigated in clinical trials for the treatment of cancer. Please enter your name and email if you would like to be notified when the abstract submission process opens.
Key Dates:
Abstract submission process begins: Early Fall, 2024
Deadline to submit abstracts for consideration: Date TBD, Fall, 2024
Please note: The selection process for the New Drugs on the Horizon series is separate from the regular and late-breaking abstract submission process for the rest of the AACR Annual Meeting.